Steven Patierno

Core Faculty

Steven Patierno, PhD

Contact

steven.patierno@duke.edu

Focus Areas
Degree

PhD, University of Texas Medical School at Houston

Dr. Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   He is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

From Scholars@Duke

Scholars@Duke Profile
Garman KS, Brown H, Alagesan P, McCall SJ, Patierno S, Wang Q, et al. Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population. Gastric Cancer. 2023 Nov 20;

Mukherjee D, Previs RA, Haines C, Al Abo M, Juras PK, Strickland KC, et al. Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis. Cancer Res. 2023 Sep 1;83(17):2889–907.

Mukherjee D, Previs RA, Haines C, Al Abo M, Juras PK, Strickland KC, et al. Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis. 2023.